{"doi":"10.1007/s00439-016-1686-2","title":"Genome editing and the next generation of antiviral therapy","abstract":null,"journal":"Human Genetics","year":2016,"id":607578,"datarank":0.5742962094733643,"base_score":3.828641396489095,"endowment":3.828641396489095,"self_citation_contribution":0.5742962094733643,"citation_network_contribution":0.0,"self_endowment_contribution":0.5742962094733643,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":45,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":384875,"name":"Nixon Niyonzima","orcid":"0000-0001-7489-6813","position":1,"is_corresponding":false},{"id":108343,"name":"Keith R. Jerome","orcid":"0000-0002-8212-3789","position":2,"is_corresponding":false},{"id":301550,"name":"Daniel Stone","orcid":"0000-0003-1619-7541","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Genome editing and the next generation of antiviral therapy","abstract":"Engineered endonucleases such as homing endonucleases (HEs), zinc finger nucleases (ZFNs), Tal-effector nucleases (TALENS) and the RNA-guided engineered nucleases (RGENs or CRISPR/Cas9) can target specific DNA sequences for cleavage, and are proving to be valuable tools for gene editing. Recently engineered endonucleases have shown great promise as therapeutics for the treatment of genetic disease and infectious pathogens. In this review, we discuss recent efforts to use the HE, ZFN, TALEN and CRISPR/Cas9 gene-editing platforms as antiviral therapeutics. We also discuss the obstacles facing gene-editing antiviral therapeutics as they are tested in animal models of disease and transition towards human application.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"27272125","pmcid":"PMC5002242","openalex_id":null,"authors":[],"funders":[{"funder_name":"National Institute of Allergy and Infectious Diseases","grant_id":"U19 AI 096111","title":null},{"funder_name":"National Institute of Allergy and Infectious Diseases","grant_id":"R21 AI117519","title":null},{"funder_name":"National Institute of Allergy and Infectious Diseases","grant_id":"R21 AI107252","title":null},{"funder_name":"National Institutes of Health","grant_id":"P30 AI 027757","title":null},{"funder_name":"National Institutes of Health","grant_id":"5U19AI096111-03","title":"Sequencing Core"},{"funder_name":"National Institutes of Health","grant_id":"5R21AI117519-02","title":"In vivo inactivation of latent HSV by endonuclease-mediated mutagenesis"},{"funder_name":"National Institutes of Health","grant_id":"5R21AI107252-02","title":"Anti-HBV therapeutics based on rare-cutting targeted endonucleases"},{"funder_name":"National Institutes of Health","grant_id":"3P30AI027757-36S1","title":"University of Washington/Fred Hutch Center for AIDS Research"}],"total_grants":8,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"green","license":"Springer TDM","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5002242","host_type":"repository"},{"url":"http://link.springer.com/content/pdf/10.1007/s00439-016-1686-2.pdf","host_type":"publisher"},{"url":"http://link.springer.com/article/10.1007/s00439-016-1686-2/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s00439-016-1686-2","host_type":"publisher"},{"url":"https://doi.org/10.1007/s00439-016-1686-2","host_type":""},{"url":"https://europepmc.org/articles/pmc5002242?pdf=render","host_type":""},{"url":"https://pubmed.ncbi.nlm.nih.gov/27272125","host_type":""},{"url":"https://dx.doi.org/10.1007/s00439-016-1686-2","host_type":""}],"fields_of_study":["0301 basic medicine","0303 health sciences","03 medical and health sciences"],"mesh_terms":["Humans","Virus Diseases","Clustered Regularly Interspaced Short Palindromic Repeats","Gene Editing"],"keywords":["Gene Editing","Virus Diseases","Humans","Clustered Regularly Interspaced Short Palindromic Repeats"],"sdg_mappings":[{"sdg_number":2,"sdg_label":"2. Zero hunger"},{"sdg_number":3,"sdg_label":"3. Good health"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-30T06:38:40.546411Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}